Ghasem Noorkhajavi

Ghasem Noorkhajavi

Auto-generated profile, based on publicly available information

Ghasem Noorkhajavi

Tabriz University of Medical Sciences

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2022 in Journal of Applied Microbiology
Verified
Journal Article
Open access
PDF file
NKNader Khani
Nader Khani
RSRoya Abedi Soleimani
Roya Abedi Soleimani
GNGhasem Noorkhajavi
Ghasem Noorkhajavi
ASAzar Abedi Soleimani
Azar Abedi Soleimani
AAAmin Abbasi
Amin Abbasi
Aziz Homayouni-RadAziz Homayouni-Rad
Aziz Homayouni-Rad
The SARS-CoV-2 pandemic defines the global health tension of our time. There are several continuous efforts to find a definitive cure in this regard. According to some adverse effects and problems of customary SARS-CoV-2 disease therapies, bioactive compounds, for example probiotics-derived metabolites (postbiotics) have been accomplishing supreme importance by investigators for adjuvant cures in patients with SARS-CoV-2. Postbiotics inhibit angiotensin-converting enzyme 2 activity and stimulate the immune system. They also boost the SARS-CoV-2 disease treatment effectiveness and reduce its adverse effects in SARS-CoV-2 illness patients as a result of antiviral and anti-inflammatory effects. Furthermore, postbiotics having unique features such as high safety, high shelf life and stability to the gastrointestinal tract can be utilized as hopeful instruments for both adjuvant and inhibition strategies in SARS-CoV-2 patients with no earnest unfavourable adverse effects. The concept of postbiotics and their biocompatible characteristics are comprehensively discussed in the present review while highlighting the bilateral relationship between postbiotic biometabolites and respiratory tract infection with a special look at the potential biological role in the inactivation of SARS-CoV-2 and reduction of related inflammatory pathways.

7 November 2023 in Probiotics and Antimicrobial Proteins
Verified
Journal Article
Closed access
PDF file
NKNader Khani
Nader Khani
GNGhasem Noorkhajavi
Ghasem Noorkhajavi
RRReza Hazrati Reziabad
Reza Hazrati Reziabad
Aziz Homayouni-RadAziz Homayouni-Rad
Aziz Homayouni-Rad
Mohammadreza ZiavandMohammadreza Ziavand
Mohammadreza Ziavand

13 March 2024 in Probiotics and Antimicrobial Proteins
Verified
Journal Article
Closed access
PDF file
NKNader Khani
Nader Khani
GNGhasem Noorkhajavi
Ghasem Noorkhajavi
RSRoya Abedi Soleimani
Roya Abedi Soleimani
RRReza Hazrati Raziabad
Reza Hazrati Raziabad
Aziz Homayouni-RadAziz Homayouni-Rad
Aziz Homayouni-Rad
AAAmir Pouya Akhlaghi
Amir Pouya Akhlaghi

5 November 2025 in Nanomedicine
Verified
Journal Article
Closed access
GNGhasem Noorkhajavi
Ghasem Noorkhajavi
SHSalar Hemmati
Salar Hemmati
MSMehdi Shahgolzari
Mehdi Shahgolzari
SFSteven Fiering
Steven Fiering
AKAhmad Yari Yari Khosroushahi
Ahmad Yari Yari Khosroushahi
Transient receptor potential melastatin 8 (TRPM8) is a cold-sensing cation channel that regulates calcium (Ca2+) levels in cells. Its overexpression is linked to tumor development and progression. TRPM8 activation by specific agonists leads to increased Ca2+ influx, causing stress and apoptosis. This stress can enhance the production and release of exosomes, which have antitumor immunity properties. We hypothesize that activating TRPM8 with nano-icilin can stimulate immune responses when administered peritumorally. 4T1 cancer cells were treated with icilin nanoparticles and hypothermia to evaluate cytotoxicity, apoptosis, calcium flux, and exosome extraction. Isolated exosomes were characterized and tested in vivo for antitumor immune response in a mouse model. Tumor growth, cytokines (IL-2, IL-12, IL-10, and IL-1β), and immunohistochemistry (IHC) were assessed. Data were analyzed using ANOVA and Duncan's test (P ≤ 0.05). TRPM8 activation by icilin nanoparticles triggers apoptosis and calcium influx in 4T1 cells. Exosomes from treated cells exhibited altered size, charge, and increased levels of DAMPs (HMGB1, HSP70). Administering these exosomes significantly inhibited tumor growth, increased CD4+/CD8+ T cells, and elevated IL-2 and IL-12, while reducing IL-10 and PD-L1, thus preventing lung metastasis. Activation of TRPM8 by icilin or cold can induce immunogenic exosomes, enhancing T cell infiltration, proinflammatory cytokines, and tumor suppression, offering a new strategy to boost immune responses against cancer.